Literature DB >> 16738250

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Sterling C Johnson1, Taylor W Schmitz, Mehul A Trivedi, Michele L Ries, Britta M Torgerson, Cynthia M Carlsson, Sanjay Asthana, Bruce P Hermann, Mark A Sager.   

Abstract

First-degree family history of sporadic Alzheimer disease (AD) and the apolipoprotein E epsilon4 (APOE4) are risk factors for developing AD. Although the role of APOE4 in AD pathogenesis has been well studied, family history remains a rarely studied and poorly understood risk factor. Both putatively cause early brain changes before symptomatic disease, but the relative contribution of each to brain function is unknown. We examined 68 middle-aged participants with a parent diagnosed with AD [family history (+FH)] and 64 age- and education-matched controls without a first-degree family history of any dementia [no family history (-FH)]. All underwent cognitive testing, APOE genotyping, and a functional magnetic resonance imaging encoding task that required discrimination of novel items from previously learned items. A 2 x 2 factorial ANOVA (presence/absence of parental family history and presence/absence of the APOE4) was used to detect group effects. A greater response to novel items was detected in the mesial temporal lobe and fusiform gyrus bilaterally among persons without a first-degree family history of AD. In hippocampal areas, the -FH +epsilon4 group exhibited the greatest signal change, and the +FH +epsilon4 group exhibited the least. These findings indicate that FH of AD is an important predictor of hippocampal activation during encoding and that FH may modulate the effect of APOE4 in these middle-aged adults, suggesting that an as yet unspecified factor embodied in first-degree family history of AD is influencing the expression of APOE4 on brain function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738250      PMCID: PMC2684824          DOI: 10.1523/JNEUROSCI.0959-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  78 in total

1.  The effect of normal aging on the coupling of neural activity to the bold hemodynamic response.

Authors:  M D'Esposito; E Zarahn; G K Aguirre; B Rypma
Journal:  Neuroimage       Date:  1999-07       Impact factor: 6.556

2.  Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI study.

Authors:  A J Saykin; S C Johnson; L A Flashman; T W McAllister; M Sparling; T M Darcey; C H Moritz; S J Guerin; J Weaver; A Mamourian
Journal:  Brain       Date:  1999-10       Impact factor: 13.501

3.  Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition.

Authors:  B L Plassman; K A Welsh-Bohmer; E D Bigler; S C Johnson; C V Anderson; M J Helms; A M Saunders; J C Breitner
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Functional MRI lateralization of memory in temporal lobe epilepsy.

Authors:  J A Detre; L Maccotta; D King; D C Alsop; G Glosser; M D'Esposito; E Zarahn; G K Aguirre; J A French
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

5.  Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease.

Authors:  S A Small; G M Perera; R DeLaPaz; R Mayeux; Y Stern
Journal:  Ann Neurol       Date:  1999-04       Impact factor: 10.422

6.  Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.

Authors:  R J Caselli; N R Graff-Radford; E M Reiman; A Weaver; D Osborne; J Lucas; A Uecker; S N Thibodeau
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

7.  Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.

Authors:  M Martinez; D Campion; A Brice; D Hannequin; B Dubois; O Didierjean; A Michon; C Thomas-Anterion; M Puel; T Frebourg; Y Agid; F Clerget-Darpoux
Journal:  Arch Neurol       Date:  1998-06

8.  Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.

Authors:  E M Reiman; A Uecker; R J Caselli; S Lewis; D Bandy; M J de Leon; S De Santi; A Convit; D Osborne; A Weaver; S N Thibodeau
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

9.  High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.

Authors:  E Ghebremedhin; C Schultz; E Braak; H Braak
Journal:  Exp Neurol       Date:  1998-09       Impact factor: 5.330

10.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

Authors:  A J Slooter; M Cruts; S Kalmijn; A Hofman; M M Breteler; C Van Broeckhoven; C M van Duijn
Journal:  Arch Neurol       Date:  1998-07
View more
  85 in total

1.  Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Authors:  Gene E Alexander; Kaitlin L Bergfield; Kewei Chen; Eric M Reiman; Krista D Hanson; Lan Lin; Daniel Bandy; Richard J Caselli; James R Moeller
Journal:  Neurobiol Aging       Date:  2012-03-08       Impact factor: 4.673

2.  White matter in aging and cognition: a cross-sectional study of microstructure in adults aged eighteen to eighty-three.

Authors:  Barbara B Bendlin; Michele E Fitzgerald; Michele L Ries; Guofan Xu; Erik K Kastman; Brent W Thiel; Howard A Rowley; Mariana Lazar; Andrew L Alexander; Sterling C Johnson
Journal:  Dev Neuropsychol       Date:  2010       Impact factor: 2.253

3.  Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.

Authors:  Lisa Mosconi; Juha O Rinne; Wai H Tsui; Valentina Berti; Yi Li; Huiyu Wang; John Murray; Noora Scheinin; Kjell Någren; Schantel Williams; Lidia Glodzik; Susan De Santi; Shankar Vallabhajosula; Mony J de Leon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

4.  Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

Authors:  Zaven S Khachaturian; Deborah Barnes; Richard Einstein; Sterling Johnson; Virginia Lee; Allen Roses; Mark A Sager; William R Shankle; Peter J Snyder; Ronald C Petersen; Gerard Schellenberg; John Trojanowski; Paul Aisen; Marilyn S Albert; John C S Breitner; Neil Buckholtz; Maria Carrillo; Steven Ferris; Barry D Greenberg; Michael Grundman; Ara S Khachaturian; Lewis H Kuller; Oscar L Lopez; Paul Maruff; Richard C Mohs; Marcelle Morrison-Bogorad; Creighton Phelps; Eric Reiman; Marwan Sabbagh; Mary Sano; Lon S Schneider; Eric Siemers; Pierre Tariot; Jacques Touchon; Bruno Vellas; Lisa J Bain
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

5.  Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

Authors:  John M Ringman; Luis D Medina; Meredith Braskie; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel A Macias-Islas; Jeffrey L Cummings; Susan Bookheimer
Journal:  Cereb Cortex       Date:  2010-08-20       Impact factor: 5.357

6.  Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.

Authors:  O C Okonkwo; G Xu; N M Dowling; B B Bendlin; A Larue; B P Hermann; R Koscik; E Jonaitis; H A Rowley; C M Carlsson; S Asthana; M A Sager; S C Johnson
Journal:  Neurology       Date:  2012-05-16       Impact factor: 9.910

7.  Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.

Authors:  N Maritza Dowling; Bruce Hermann; Asenath La Rue; Mark A Sager
Journal:  Neuropsychology       Date:  2010-11       Impact factor: 3.295

8.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

9.  Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.

Authors:  Willem Huijbers; Aaron P Schultz; Kathryn V Papp; Molly R LaPoint; Bernard Hanseeuw; Jasmeer P Chhatwal; Trey Hedden; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2018-11-27       Impact factor: 6.167

Review 10.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.